In8bio Stock Forward View - Simple Moving Average
| INAB Stock | USD 1.87 -0.04 -2.09% |
The successful prediction of In8bio's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with In8bio Inc, which may create opportunities for some arbitrage if properly timed.
As of today, the 14-period RSI for In8bio stands at 52, indicating neutral momentum. Values near 50 generally reflect equilibrium between upward and downward pressure.Momentum
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter -0.78 | EPS Estimate Current Year -3.22 | EPS Estimate Next Year -1.72 | Wall Street Target Price 6.25 | EPS Estimate Current Quarter -1.25 |
This view frames how In8bio Inc responds to recent headlines and peer activity within its market context.
The Simple Moving Average forecasted value of In8bio Inc on the next trading day is expected to be 1.89 with a mean absolute deviation of 0.11 and the sum of the absolute errors of 6.24.In8bio after-hype prediction price | $ 1.94 |
Sentiment indicators are one input among forecasting models, technical signals, analyst estimates, earnings data, and momentum measures.
Use Historical Fundamental Analysis of In8bio to cross-verify projections for In8bio. The view provides historical context for the projection set.In8bio Additional Predictive Modules
Most predictive techniques to examine In8bio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for In8bio using various technical indicators. When you analyze In8bio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Simple Moving Average Price Forecast For the 14th of March 2026
Given 90 days horizon, the Simple Moving Average forecasted value of In8bio Inc on the next trading day is expected to be 1.89 with a mean absolute deviation of 0.11 , mean absolute percentage error of 0.02 , and the sum of the absolute errors of 6.24 .Please note that although there have been many attempts to predict In8bio Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that In8bio's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest In8bio | In8bio Price Prediction | Research Analysis |
Forecasted Value
This next-day forecast for In8bio Inc uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of In8bio stock data series using in forecasting. Note that when a statistical model is used to represent In8bio stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 110.5092 |
| Bias | Arithmetic mean of the errors | -0.0088 |
| MAD | Mean absolute deviation | 0.1058 |
| MAPE | Mean absolute percentage error | 0.0545 |
| SAE | Sum of the absolute errors | 6.24 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of In8bio's price to converge to an average value over time is called mean reversion.
After-Hype Price Density Analysis
As far as predicting the price of In8bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
In the context of predicting In8bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on In8bio's historical news coverage.
Current Value
The after-hype framework applied to In8bio Inc assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as In8bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading In8bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with In8bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.51 | 6.81 | 0.02 | 0.10 | 10 Events | 6 Events | In 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.87 | 1.94 | 1.04 |
|
Hype Timeline
In8bio Inc is currently traded for 1.87. The company has historical hype elasticity of 0.02, and average elasticity to hype of competition of 0.1. In8bio is forecasted to increase in value after the next headline, with the price projected to jump to 1.94 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 1.04%, whereas the daily expected return is currently at 0.51%. The volatility of related hype on In8bio is about 3321.95%, with the expected price after the next announcement by competition of 1.97. Net Loss for the year was -30.44 M with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next forecasted press release will be in 10 days. Use Historical Fundamental Analysis of In8bio to cross-verify projections for In8bio. The view provides historical context for the projection set.Related Hype Analysis
Having access to credible news sources related to In8bio's direct competition is more important than ever and may enhance your ability to predict In8bio's future price movements. Getting to know how In8bio's peers react to changing market sentiment, related social.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RNAZ | Transcode Therapeutics | 0.57 | 6 per month | 4.91 | 0.07 | 16.20 | -7.47 | 35.66 | |
| APVO | Aptevo Therapeutics | -0.59 | 9 per month | 0.00 | -0.30 | 6.56 | -11.40 | 40.48 | |
| HCWB | HCW Biologics | 0.1 | 6 per month | 0.00 | -0.24 | 8.11 | -11.97 | 42.74 | |
| LYRA | Lyra Therapeutics | 0.06 | 5 per month | 0.00 | -0.15 | 13.48 | -15.12 | 53.33 | |
| KPRX | Kiora Pharmaceuticals | -0.02 | 4 per month | 2.48 | 0.03 | 3.96 | -3.90 | 12.37 | |
| GLTO | Galecto | 2.24 | 7 per month | 7.02 | 0.11 | 14.48 | -12.23 | 45.55 | |
| APRE | Aprea Therapeutics | -0.17 | 10 per month | 0.00 | -0.03 | 11.29 | -8.43 | 46.26 | |
| ACXP | Acurx Pharmaceuticals LLC | -0.03 | 6 per month | 4.79 | 0.10 | 38.01 | -9.34 | 49.19 | |
| BCDA | Biocardia | -0.06 | 6 per month | 0.00 | -0.0024 | 5.98 | -6.03 | 20.06 | |
| PHIO | Phio Pharmaceuticals Corp | -0.05 | 9 per month | 5.77 | 0.03 | 13.86 | -10.53 | 56.33 |
Other Forecasting Options for In8bio
For every potential investor in In8bio, whether a beginner or expert, In8bio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better.In8bio Related Equities
The following equities are related to In8bio within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing In8bio against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
In8bio Market Strength Events
Market strength indicators help investors to evaluate how In8bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading In8bio shares will generate the highest return on.
In8bio Risk Indicators
The analysis of In8bio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in In8bio's investment and either accepting that risk or mitigating it.
| Mean Deviation | 4.61 | |||
| Semi Deviation | 4.8 | |||
| Standard Deviation | 6.62 | |||
| Variance | 43.83 | |||
| Downside Variance | 25.46 | |||
| Semi Variance | 23.01 | |||
| Expected Short fall | -5.57 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for In8bio
Coverage intensity for In8bio Inc matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
In8bio Short Properties
Short sentiment tied to In8bio Inc matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 53.5 M | |
| Cash And Short Term Investments | 11.1 M |
More Resources for In8bio Stock Analysis
A structured review of In8bio Inc often starts with core financial statements and trend context. Key ratios help frame profitability, efficiency, and growth context for In8bio Inc Stock. Outlined below are key reports that provide context for In8bio Inc Stock:Use Historical Fundamental Analysis of In8bio to cross-verify projections for In8bio. The view provides historical context for the projection set. Analysis related to In8bio should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
The market value of In8bio Inc is measured differently than book value, which reflects In8bio accounting equity. In8bio's market capitalization is 19.43 M. A P/B ratio of 1.38 indicates the market values In8bio above its accounting book value. Enterprise value stands at 11.7 M. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
Note that In8bio's intrinsic value and market price are different measures derived from different inputs. For In8bio, key inputs include a P/B ratio of 1.38, and ROE of -1.9%. By contrast, market price reflects the level where buyers and sellers transact.